Oregon Public Employees Retirement Fund decreased its stake in shares of Tenet Healthcare Co. (NYSE:THC – Free Report) by 0.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,342 shares of the company’s stock after selling 160 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Tenet Healthcare were worth $2,442,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Plato Investment Management Ltd bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $28,000. True Wealth Design LLC bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $38,000. Kestra Investment Management LLC bought a new position in shares of Tenet Healthcare during the 4th quarter worth approximately $60,000. Hantz Financial Services Inc. bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $83,000. Finally, Venturi Wealth Management LLC boosted its stake in shares of Tenet Healthcare by 36.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 521 shares of the company’s stock worth $87,000 after acquiring an additional 138 shares during the period. 95.44% of the stock is currently owned by institutional investors.
Tenet Healthcare Price Performance
Tenet Healthcare stock opened at $130.48 on Friday. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a 52 week low of $88.98 and a 52 week high of $171.20. The stock has a market capitalization of $12.41 billion, a P/E ratio of 4.05, a price-to-earnings-growth ratio of 1.02 and a beta of 2.05. The stock has a fifty day moving average of $133.09 and a 200-day moving average of $147.25.
Analyst Ratings Changes
Several research firms recently issued reports on THC. TD Cowen began coverage on Tenet Healthcare in a research note on Wednesday. They issued a “buy” rating and a $175.00 price target for the company. Raymond James downgraded Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a research note on Friday, November 22nd. KeyCorp reduced their price target on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Cantor Fitzgerald restated an “overweight” rating and issued a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Finally, StockNews.com upgraded Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $163.88.
Check Out Our Latest Stock Report on THC
Tenet Healthcare Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading
- Five stocks we like better than Tenet Healthcare
- What Are Dividend Challengers?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What Are the U.K. Market Holidays? How to Invest and Trade
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Compound Interest and Why It Matters When Investing
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.